| P50 | author | Nancy Cox | Q6962616 |
| P2093 | author name string | N H Arden | |
| | J M Katz | |
| | L G Rudenko | |
| | A I Klimov | |
| | R C Holman | |
| | A DeGuzman | |
| | S Donina | |
| | A Naychin | |
| | A Rekstin | |
| | E Grigorieva | |
| | J Desheva | |
| P2860 | cites work | The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. | Q50602332 |
| | Prevalence of Antibody to Current Influenza Viruses and Effect of Vaccination on Antibody Response | Q55120119 |
| | Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic | Q57108181 |
| | Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic | Q70052527 |
| | Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers | Q70545771 |
| | Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza | Q71120792 |
| | A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease | Q72695855 |
| | The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial | Q72821242 |
| | Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions | Q77367126 |
| | Pandemic versus epidemic influenza mortality: a pattern of changing age distribution | Q28275622 |
| | The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children | Q34467468 |
| | A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection | Q36258297 |
| | Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines | Q37163516 |
| | Antibody induction by influenza vaccines in the elderly: a review of the literature | Q38719169 |
| | Determinants of immunity to influenza infection in man | Q39784922 |
| | Serious morbidity and mortality associated with influenza epidemics | Q40246988 |
| | Measuring vaccine efficacy from epidemics of acute infectious agents | Q40888285 |
| | Inactivated influenza vaccines. 2. Laboratory indices of protection | Q41243525 |
| | Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. | Q43208959 |
| | Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren | Q43208988 |
| | Observations on excess mortality associated with epidemic influenza | Q43210362 |
| | Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine | Q43459234 |
| | Immunization of elderly people with high doses of influenza vaccine | Q43899064 |
| | Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults | Q44955734 |
| | Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine | Q44959009 |
| | Reduced Infectivity of Cold-Adapted Influenza A H1N1 Viruses in the Elderly: Correlation with Serum and Local Antibodies | Q44967688 |
| | Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial | Q45748324 |
| | A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA. | Q45750290 |
| | Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects | Q45753400 |
| | Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly | Q45771986 |
| | Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults | Q45779739 |
| | Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine | Q45784978 |
| | Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly | Q45828380 |
| | Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly | Q45868418 |
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza vaccine | Q383260 |
| | attenuated vaccine | Q1810913 |
| P304 | page(s) | 308-318 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents | |
| P478 | volume | 19 | |